Transdermal pharmaceutical composition
US5523094A · kind A · utility
6Cited by
3References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 20, 1994 |
| Grant date | Jun 4, 1996 |
| Priority date | — |
| Expiry date | Jul 20, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical preparation intended for transdermal administration contains alfusozin [(N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydr o-2-furancarboxamide] or a salt thereof and a mixture composed of water, at least one organic solvent and at least one absorption promoter.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.